National Pharmaceutical Pricing Authority revises stent prices

The National Pharmaceutical Pricing Authority has revised the price of drug eluting stents (DES) downwards by about Rs 2,300. These caps are excluding GST. With DES accounting for about 95% of all stents used in India, this means most stents will become cheaper. Revised price caps will remain in effect till March 31, 2019.

For More information on this news visit:
Connect with us on Social platform at
Subscribe to our YouTube Channel:

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *